BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 22658578)

  • 1. Anti-class II -DR humanized monoclonal antibody, IMMU-114, blocks allogeneic immune response.
    Park KH; Sawada T; Murakami T; Ishii Y; Yasuo M; Fuchinoue S; Goldenberg DM; Kubota K
    Am J Surg; 2012 Oct; 204(4):527-34. PubMed ID: 22658578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-human leukocyte antigen-DR (MHC class II) humanized monoclonal antibody, IMMU-114, suppresses human to bovine cellular responses.
    Park KH; Sawada T; Murakami T; Ishii Y; Yasuo M; Urakawa M; Aoyagi Y; Fuchinoue S; Kubota K
    J Surg Res; 2012 Nov; 178(1):472-7. PubMed ID: 22487390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The humanized anti-HLA-DR moAb, IMMU-114, depletes APCs and reduces alloreactive T cells: implications for preventing GVHD.
    Chen X; Chang CH; Stein R; Goldenberg DM
    Bone Marrow Transplant; 2012 Jul; 47(7):967-80. PubMed ID: 22020022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in cytokine production and composition of peripheral blood leukocytes during pregnancy are not associated with a difference in the proliferative immune response to the fetus.
    Lashley LE; van der Hoorn ML; van der Mast BJ; Tilburgs T; van der Lee N; van der Keur C; van Beelen E; Roelen DL; Claas FH; Scherjon SA
    Hum Immunol; 2011 Oct; 72(10):805-11. PubMed ID: 21708204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Campath-1G impairs human natural killer (NK) cell-mediated cytotoxicity.
    Condiotti R; Nagler A
    Bone Marrow Transplant; 1996 Oct; 18(4):713-20. PubMed ID: 8899185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A soluble product of human corneal fibroblasts inhibits lymphocyte activation. Enhancement by interferon-gamma.
    Donnelly JJ; Xi MS; Rockey JH
    Exp Eye Res; 1993 Feb; 56(2):157-65. PubMed ID: 8462649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.
    Whiteside TL; Letessier E; Hirabayashi H; Vitolo D; Bryant J; Barnes L; Snyderman C; Johnson JT; Myers E; Herberman RB
    Cancer Res; 1993 Dec; 53(23):5654-62. PubMed ID: 8242620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon.
    Masuyama J; Minato N; Kano S
    J Clin Invest; 1986 May; 77(5):1596-605. PubMed ID: 3084562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory properties of FK734, a humanized anti-CD28 monoclonal antibody with agonistic and antagonistic activities.
    Shiao SL; McNiff JM; Masunaga T; Tamura K; Kubo K; Pober JS
    Transplantation; 2007 Feb; 83(3):304-13. PubMed ID: 17297405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell functions of IL-2-activated tumor-infiltrating lymphocytes from renal cell carcinoma.
    Morita T; Salmeron MA; Hayakawa K; Swanson DA; von Eschenbach AC; Itoh K
    Reg Immunol; 1992; 4(4):225-35. PubMed ID: 1476875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS; Krishnadas DK; Agrawal B
    Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity mediated by chimeric anti-GD3 monoclonal antibody KM871.
    Liu Z; Lee FT; Hanai N; Smyth FE; Burgess AW; Old LJ; Scott AM
    Cancer Immun; 2002 Oct; 2():13. PubMed ID: 12747758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.
    Shimizu Y; Weidmann E; Iwatsuki S; Herberman RB; Whiteside TL
    Cancer Res; 1991 Nov; 51(22):6153-62. PubMed ID: 1718596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses by cord blood cells.
    Roncarolo MG; Bigler M; Ciuti E; Martino S; Tovo PA
    Blood Cells; 1994; 20(2-3):573-85; discussion 585-6. PubMed ID: 7749123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
    Bamias A; Koutsoukou V; Terpos E; Tsiatas ML; Liakos C; Tsitsilonis O; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Papatheodoridis G; Archimandritis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2008 Feb; 108(2):421-7. PubMed ID: 18036640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
    Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T
    Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vitro coculture model to study cytokine profiles of natural killer cells during maternal immune cell-trophoblast interactions.
    Ntrivalas E; Kwak-Kim J; Beaman K; Mantouvalos H; Gilman-Sachs A
    J Soc Gynecol Investig; 2006 Apr; 13(3):196-202. PubMed ID: 16516503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.